Leading global vaccine products by revenue 2023
This statistic displays the leading 10 global vaccine products based on their revenues worldwide in 2023. Pfizer's COVID-19 vaccine Comirnaty generated nearly 11.2 billion U.S. dollars in revenues in that year.
Top vaccine products
Vaccines act as a preventive measure to improve immunity to certain diseases. Often, vaccines are created from a weakened or killed form of a microbe which allows the immune system to react and create a record of it, so that in the future, it can easily recognize these microorganisms. Vaccine use can easily help to prevent contraction of certain viruses such as influenza. However, some countries may not have easy access to vaccinations.
The global vaccination market is projected to reach around 95 billion U.S. dollars in 2029. In 2023, Comirnaty and Gardasil were the top revenue generating vaccines in the world, generating 11.2 billion and 68.9 billion U.S. dollars, respectively. Comirnaty is marketed by Pfizer and BioNTech, while Gardasil is marketed by Merck & Co.
